Drug chains forge ahead amid uncertainty
It’s fair to say that the chain drug industry is at a turning point.
Opinion
Health Equity 3.0
In her keynote address, Rina Shah, senior vice president of pharmacy growth at Walgreens, described how health equity emerged as a central consideration in the drug chain’s strategic planning process and what that means going forward
It’s time to rethink the drug store model
Reimbursements have declined to a point at which pharmacies lose money when they fill some scripts.
Flawed health system needs overhaul
“The U.S. is failing one of its principal obligations as a nation: to protect the health and welfare of its people,” says Dr. Joseph Betancourt, president of the Commonwealth Fund.
Health care gravitates toward retail setting
During an Insight Session at last month’s NACDS Total Store Expo in Boston, O’Connor discussed how the manner in which buyers and sellers interact will evolve at an ever-accelerating rate.
Building trust with consumers is critical for brands
Trust is crucial for achieving customer loyalty and repeat purchases, as well as creating brand evangelists, and authenticity is a cornerstone of building consumer trust.
PBM reform: The end of the beginning
The recent release of an interim report by the Federal Trade Commission about what the agency characterizes as “prescription drug middlemen” represents a vindication of sorts for pharmacy advocates who have long contended that PBMs employ business practices that skew the market to their advantage.